Tori Allen says she’s thrilled to have lost 80 pounds since she went on Wegovy, one of the GLP-1 drugs that more and more ...

a buy? Weight-loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound are generating billions of dollars in sales Pharma rival Novo Nordisk (NYSE:NVO) was the first to market with its ...

Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of years thanks to new technologies, former U.S. Treasury Secretary ...

For the company to continue to grow at the same pace it has been recently, its blockbuster drugs, specifically its weight loss drug Wegovy, need to continue to retain a sizable share of the market.

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their ...

Wegovy has been approved by the Food and Drug Administration ... rather than the insurance company. If you buy insurance on the marketplace, Blue Cross Blue Shield usually is the best company for ...

The company's most famous brands, Wegovy and Ozempic ... Novo Nordisk remains an excellent pharmaceutical stock to buy and hold. AstraZeneca's strategy is different from Novo Nordisk's.

Specifically, Allen has had to buy new clothes - some $5,000 worth ... Many people on these weight-loss drugs - which include Ozempic, Wegovy, Zepbound and Mounjaro - report that they're shelling ...